TipRanks
Advertisement
Advertisement

RCKT Stock Latest News

Rocket Pharmaceuticals Secures Hercules Loan to Extend Runway
Company AnnouncementsRocket Pharmaceuticals Secures Hercules Loan to Extend Runway
8h ago
8K
RCKT
Rocket Pharmaceuticals secures $150M credit facility from Hercules Capital
PremiumThe Fly
Rocket Pharmaceuticals secures $150M credit facility from Hercules Capital
9h ago
HTGC
RCKT
Rocket, Copart, Pegasystems, Abeona, Fluence trending by analysts
PremiumWeekend Updates
Rocket, Copart, Pegasystems, Abeona, Fluence trending by analysts
18d ago
ABEO
CPRT
Starbucks initiated, Expedia downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Starbucks initiated, Expedia downgraded: Wall Street’s top analyst calls
21d ago
NU
BAP
Video: Intel up on reported memory chip manufacturing talks with SK Hynix
PremiumThe Fly
Video: Intel up on reported memory chip manufacturing talks with SK Hynix
21d ago
ALVO
INTC
Needham upgrades Rocket Pharmaceuticals after FDA reaffirms Danon study design
PremiumThe FlyNeedham upgrades Rocket Pharmaceuticals after FDA reaffirms Danon study design
21d ago
RCKT
Rocket Pharmaceuticals upgraded to Buy from Hold at Needham
Premium
The Fly
Rocket Pharmaceuticals upgraded to Buy from Hold at Needham
21d ago
RCKT
Rocket Pharmaceuticals: FDA Alignment De-Risks Danon Program, Safety Data Strengthens Outlook as Buy Rating Reiterated with Unchanged $15 Price Target
Premium
Ratings
Rocket Pharmaceuticals: FDA Alignment De-Risks Danon Program, Safety Data Strengthens Outlook as Buy Rating Reiterated with Unchanged $15 Price Target
22d ago
RCKT
Rocket Pharmaceuticals advances pivotal Danon disease trial
PremiumCompany Announcements
Rocket Pharmaceuticals advances pivotal Danon disease trial
22d ago
8K
RCKT
Rocket announces FDA alignment on path to complete Phase 2 trial of RP-A501
PremiumThe Fly
Rocket announces FDA alignment on path to complete Phase 2 trial of RP-A501
22d ago
RCKT
Rocket Pharmaceuticals Establishes New Severance and Executive Agreements
PremiumCompany Announcements
Rocket Pharmaceuticals Establishes New Severance and Executive Agreements
1M ago
8K
RCKT
Rocket Pharmaceuticals: Buy Rating Reaffirmed on Strengthened Financial Position, Clinical Progress, and Unchanged $10 Price Target
PremiumRatings
Rocket Pharmaceuticals: Buy Rating Reaffirmed on Strengthened Financial Position, Clinical Progress, and Unchanged $10 Price Target
2M ago
RCKT
Rocket Pharmaceuticals price target lowered to $15 from $16 at Wedbush
PremiumThe FlyRocket Pharmaceuticals price target lowered to $15 from $16 at Wedbush
2M ago
RCKT
Rocket Pharmaceuticals: Advancing Gene Therapy Pipeline and Regulatory Momentum Support Buy Rating Despite Price Target Trim to $15
Premium
Ratings
Rocket Pharmaceuticals: Advancing Gene Therapy Pipeline and Regulatory Momentum Support Buy Rating Despite Price Target Trim to $15
2M ago
RCKT
Rocket Pharmaceuticals reports Q2 EPS $1.08, consensus 35c
Premium
The Fly
Rocket Pharmaceuticals reports Q2 EPS $1.08, consensus 35c
2M ago
RCKT
Is RCKT a Buy, Before Earnings?
PremiumPre-Earnings
Is RCKT a Buy, Before Earnings?
2M ago
RCKT
Rocket Pharmaceuticals Retains Hold Rating as Early Danon Phase 2 Safety Data Ease Concerns but Regulatory Path Keeps Risk‑Reward Balanced
PremiumRatings
Rocket Pharmaceuticals Retains Hold Rating as Early Danon Phase 2 Safety Data Ease Concerns but Regulatory Path Keeps Risk‑Reward Balanced
2M ago
RCKT
Rocket Pharmaceuticals Reports Positive Danon Disease Safety Update
PremiumCompany Announcements
Rocket Pharmaceuticals Reports Positive Danon Disease Safety Update
2M ago
8K
RCKT
Rocket announces safety update from three patients treated with RP-A501
PremiumThe Fly
Rocket announces safety update from three patients treated with RP-A501
2M ago
RCKT
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
PremiumMarket NewsRedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
4M ago
GILD
JAZZ
Rocket Pharmaceuticals Strengthens Cash Position via Voucher Sale
Premium
Company Announcements
Rocket Pharmaceuticals Strengthens Cash Position via Voucher Sale
4M ago
8K
RCKT
Rocket Pharmaceuticals closes sale of Rare Pediatric Disease PRV for $180M
Premium
The Fly
Rocket Pharmaceuticals closes sale of Rare Pediatric Disease PRV for $180M
4M ago
RCKT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >